Clinical Trial Update: A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-masked trial evaluating autologous serum eye drops for severe ocular chronic graft-versus-host disease in HSCT patients; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Autologous serum eye drops (autologous serum)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Graft vs Host Disease | Phase 2 | Status: TERMINATED | Results posted: 2016-09-13